Bio-Techne Corp
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $72.75
- 52-Week Range
- $43.20 – $72.88
- Market Cap
- $11.42B
- P/E (TTM)
- 66.70
- EPS (TTM)
- 1.09
- Dividend Yield
- 0.44%
Advanced Metrics
- Price/Book
- 5.27
- PEG Ratio
- 2.17
- Return on Equity
- 8.33%
- Return on Assets
- 6.45%
- Gross Margin
- 66.17%
- Operating Margin
- 21.69%
- Profit Margin
- 14.00%
- Current Ratio
- 2.28
- Debt/Equity
- 0.13
- Total Debt
- $285.56M
- Free Cash Flow
- $277.76M
- Revenue Growth
- 4.60%
- Earnings Growth
- -25.00%
- Enterprise Value
- $11.35B
Market Snapshot
About
Bio-Techne Corp. is a global life sciences company that develops and manufactures high-quality reagents, analytical instruments, and diagnostic products for the research and clinical diagnostic markets. The company serves biopharmaceutical, academic, and diagnostic customers worldwide. Bio-Techne operates through two segments: Protein Sciences and Diagnostics and Genomics.